Main > ONCOLOGY (**) > Colon Cancer>MET *** > Treatment > DE. B. Regorafenib *
DE. B. Regorafenib *'s subsections
(*) CN, EU & JP Approval Date: ?
(*) USA Approval Date: 2012. 09.27
Company
Oral Multi-KInase Inhibition
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2017. 04.25.
TradeMark
TradeMark Web-Site
UpDate: 2017. 04.29.
DE. B. Regorafenib *'s products
This section has no products